142 related articles for article (PubMed ID: 34355656)
1. The ubiquitous role of spleen tyrosine kinase (Syk) in gut diseases: From mucosal immunity to targeted therapy.
Gong W; Liu P; Zheng T; Wu X; Zhao Y; Ren J
Int Rev Immunol; 2022; 41(5):552-563. PubMed ID: 34355656
[TBL] [Abstract][Full Text] [Related]
2. Role of spleen tyrosine kinase in liver diseases.
Kurniawan DW; Storm G; Prakash J; Bansal R
World J Gastroenterol; 2020 Mar; 26(10):1005-1019. PubMed ID: 32205992
[TBL] [Abstract][Full Text] [Related]
3. Genetic and Pharmacological Dissection of the Role of Spleen Tyrosine Kinase (Syk) in Intestinal Inflammation and Immune Dysfunction in Inflammatory Bowel Diseases.
Biagioli M; Mencarelli A; Carino A; Cipriani S; Marchianò S; Fiorucci C; Donini A; Graziosi L; Baldelli F; Distrutti E; Costantino G; Fiorucci S
Inflamm Bowel Dis; 2017 Dec; 24(1):123-135. PubMed ID: 29272492
[TBL] [Abstract][Full Text] [Related]
4. Dectin-1-mediated signaling leads to characteristic gene expressions and cytokine secretion via spleen tyrosine kinase (Syk) in rat mast cells.
Kimura Y; Chihara K; Honjoh C; Takeuchi K; Yamauchi S; Yoshiki H; Fujieda S; Sada K
J Biol Chem; 2014 Nov; 289(45):31565-75. PubMed ID: 25246527
[TBL] [Abstract][Full Text] [Related]
5. Phosphorylated immunoreceptor tyrosine-based activation motifs and integrin cytoplasmic domains activate spleen tyrosine kinase via distinct mechanisms.
Antenucci L; Hytönen VP; Ylänne J
J Biol Chem; 2018 Mar; 293(13):4591-4602. PubMed ID: 29440271
[TBL] [Abstract][Full Text] [Related]
6. Recent advance of spleen tyrosine kinase in diseases and drugs.
Shao Y; Zhang S; Zhang Y; Liu Z
Int Immunopharmacol; 2021 Jan; 90():107168. PubMed ID: 33264719
[TBL] [Abstract][Full Text] [Related]
7. CCL4-mediated targeting of spleen tyrosine kinase (Syk) inhibitor using nanoparticles alleviates inflammatory bowel disease.
Gong W; Yu J; Zheng T; Liu P; Zhao F; Liu J; Hong Z; Ren H; Gu G; Wang G; Wu X; Zhao Y; Ren J
Clin Transl Med; 2021 Feb; 11(2):e339. PubMed ID: 33634985
[TBL] [Abstract][Full Text] [Related]
8. Spleen tyrosine kinase (SYK) is a potential target for the treatment of cutaneous lupus erythematosus patients.
Braegelmann C; Hölzel M; Ludbrook V; Dickson M; Turan N; Ferring-Schmitt S; Sternberg S; Bieber T; Kuhn A; Wenzel J
Exp Dermatol; 2016 May; 25(5):375-9. PubMed ID: 26910509
[TBL] [Abstract][Full Text] [Related]
9. The transmembrane adapter SCIMP recruits tyrosine kinase Syk to phosphorylate Toll-like receptors to mediate selective inflammatory outputs.
Liu L; Lucas RM; Nanson JD; Li Y; Whitfield J; Curson JEB; Tuladhar N; Alexandrov K; Mobli M; Sweet MJ; Kobe B; Stow JL; Luo L
J Biol Chem; 2022 May; 298(5):101857. PubMed ID: 35337798
[TBL] [Abstract][Full Text] [Related]
10. Downregulation of the Syk Signaling Pathway in Intestinal Dendritic Cells Is Sufficient To Induce Dendritic Cells That Inhibit Colitis.
Hang L; Blum AM; Kumar S; Urban JF; Mitreva M; Geary TG; Jardim A; Stevenson MM; Lowell CA; Weinstock JV
J Immunol; 2016 Oct; 197(7):2948-57. PubMed ID: 27559049
[TBL] [Abstract][Full Text] [Related]
11. Assessment of the effects of Syk and BTK inhibitors on GPVI-mediated platelet signaling and function.
Zheng TJ; Lofurno ER; Melrose AR; Lakshmanan HHS; Pang J; Phillips KG; Fallon ME; Kohs TCL; Ngo ATP; Shatzel JJ; Hinds MT; McCarty OJT; Aslan JE
Am J Physiol Cell Physiol; 2021 May; 320(5):C902-C915. PubMed ID: 33689480
[TBL] [Abstract][Full Text] [Related]
12. Selective inhibition of spleen tyrosine kinase (SYK) with a novel orally bioavailable small molecule inhibitor, RO9021, impinges on various innate and adaptive immune responses: implications for SYK inhibitors in autoimmune disease therapy.
Liao C; Hsu J; Kim Y; Hu DQ; Xu D; Zhang J; Pashine A; Menke J; Whittard T; Romero N; Truitt T; Slade M; Lukacs C; Hermann J; Zhou M; Lucas M; Narula S; DeMartino J; Tan SL
Arthritis Res Ther; 2013 Oct; 15(5):R146. PubMed ID: 24286216
[TBL] [Abstract][Full Text] [Related]
13. Cholesterol crystals activate Syk and PI3 kinase in human macrophages and dendritic cells.
Corr EM; Cunningham CC; Dunne A
Atherosclerosis; 2016 Aug; 251():197-205. PubMed ID: 27356299
[TBL] [Abstract][Full Text] [Related]
14. Spleen Tyrosine Kinase as a Target Therapy for Pseudomonas aeruginosa Infection.
Alhazmi A
J Innate Immun; 2018; 10(4):255-263. PubMed ID: 29925062
[TBL] [Abstract][Full Text] [Related]
15. Identification of natural product-based effective inhibitors of spleen tyrosine kinase (SYK) through virtual screening and molecular dynamics simulation approaches.
Ali T; Anjum F; Choudhury A; Shafie A; Ashour AA; Almalki A; Mohammad T; Hassan MI
J Biomol Struct Dyn; 2024 Apr; 42(7):3459-3471. PubMed ID: 37261484
[TBL] [Abstract][Full Text] [Related]
16. Dual Role of the Tyrosine Kinase Syk in Regulation of Toll-Like Receptor Signaling in Plasmacytoid Dendritic Cells.
Aouar B; Kovarova D; Letard S; Font-Haro A; Florentin J; Weber J; Durantel D; Chaperot L; Plumas J; Trejbalova K; Hejnar J; Nunès JA; Olive D; Dubreuil P; Hirsch I; Stranska R
PLoS One; 2016; 11(6):e0156063. PubMed ID: 27258042
[TBL] [Abstract][Full Text] [Related]
17. SYK-CARD9 Signaling Axis Promotes Gut Fungi-Mediated Inflammasome Activation to Restrict Colitis and Colon Cancer.
Malik A; Sharma D; Malireddi RKS; Guy CS; Chang TC; Olsen SR; Neale G; Vogel P; Kanneganti TD
Immunity; 2018 Sep; 49(3):515-530.e5. PubMed ID: 30231985
[TBL] [Abstract][Full Text] [Related]
18. The Activating C-type Lectin-like Receptor NKp65 Signals through a Hemi-immunoreceptor Tyrosine-based Activation Motif (hemITAM) and Spleen Tyrosine Kinase (Syk).
Bauer B; Wotapek T; Zöller T; Rutkowski E; Steinle A
J Biol Chem; 2017 Feb; 292(8):3213-3223. PubMed ID: 28082678
[TBL] [Abstract][Full Text] [Related]
19. A reevaluation of the spleen tyrosine kinase (SYK) activation mechanism.
Mansueto MS; Reens A; Rakhilina L; Chi A; Pan BS; Miller JR
J Biol Chem; 2019 May; 294(19):7658-7668. PubMed ID: 30923129
[TBL] [Abstract][Full Text] [Related]
20. The nonreceptor tyrosine kinase SYK drives caspase-8/NLRP3 inflammasome-mediated autoinflammatory osteomyelitis.
Dasari TK; Geiger R; Karki R; Banoth B; Sharma BR; Gurung P; Burton A; Kanneganti TD
J Biol Chem; 2020 Mar; 295(11):3394-3400. PubMed ID: 31719149
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
